Journal of ISSN: 2373-6410JNSK

Neurology & Stroke
Case Report
Volume 4 Issue 3 - 2016
A Case of Miller Fisher Syndrome with Unusual Features: Normal Muscle Stretch Reflexes and Facial Palsy and Dramatic Response to IVIG
Mahnaz Talebi1, Mohammad Amin Farzi2* and Mozhgan Hadavi Bavil3
1Professor of neurology, neurosciences research center (NSRC), Imam Reza Medical Center, Tabriz University of medical sciences, Iran
2Neurology resident, Neurosciences Research Center (NSRC), Imam Reza Medical Center, Tabriz University of medical sciences, Iran
3Cardiology Resident, Madani Heart Center, Tabriz University of medical sciences, Iran
Received:August 07, 2015 | Published: March 08, 2016
*Corresponding author: Mohammad Amin Farzi, Neurology resident, Neurosciences Research Center (NSRC), Imam Reza Medical Center, Tabriz University of medical sciences, Iran, Email:
Citation: Talebi M, Farzi MA, Bavil H (2016) A Case of Miller Fisher Syndrome with Unusual Features: Normal Muscle Stretch Reflexes and Facial Palsy and Dramatic Response to IVIG. J Neurol Stroke 4(3): 00131. DOI: 10.15406/jnsk.2016.04.00131


The Miller Fisher syndrome a variant of the Guillain-Barre syndrome characterized by the acute onset of oculomotor dysfunction, ataxia, and loss of deep tendon reflexes with relative sparing of strength in the extremities and trunk. Patient is presented here was a young female came with ataxia and ophthalmoplegia and unusual features of normal muscle stretch reflexes and had absent sural SNAP (Sensory Nerve Action Potential) in nerve conduction study. Patient was treated with IVIG and patient showed dramatic response to IVIG so she was symptom free in third day of treatment with IVIG.

Keywords: Guillain-Barre syndrome; Miller Fisher syndrome; IVIG


A 34 years old female that was good till when developed with upper respiratory infection. Her problem was resolved at that time but two weeks later she developed double vision and “wobbly” gait with inability to walk and difficulty in standing. Few days later she was unable to keep open her eyes. Then she visited neurologist and received Dexamethason in outpatient setting with the diagnosis of cerebellitis after obtaining neuroimaging. But no improvement was seen in her condition after 2 weeks so she admitted in hospital Neurology ward for further evaluation. Patient had past medical history of Minor Thalassemia. Her family history for similar condition was negative. Her drug history was negative except the dexamethasone use for past 8 days. On physical examination, her blood pressure was 110/80 mm Hg,heart rate was 76/min, and respiratory rate was 14/min. Patient was alert, and oriented to time, place and person. On cranial nerve examination visual field and acuity were normal Pupils were equal and reactive to light; Fundoscopy revealed sharp disk, there was right sixth cranial nerve palsy , Impaired upward gaze in both eyes and bilateral ptosis, difficulty in showing teeth and blowing and eyebrow elevation in both sides suggestive bilateral peripheral facial paresis and left 12th nerve palsy. Other cranial nerves were normal.

Muscle stretch reflexes were 2+in all four extremities. Plantar response was flexor; there was no focal motor weakness of upper limbs. The finger to finger and heel to shin tests was impaired in both upper and lower extremities, and gait was ataxic. There was no sensory deficit and position and vibration senses were normal. Electrocardiogram showed sinus rhythm. WBC was 11.2×109/L and erythrocyte sedimentation rate was 18 mm/h thyroid function test was normal. Brain CT and Magnetic resonance imaging of the brain also were normal. Repetitive Stimulation tests showed normal results and acetylcholine receptor antibody was negative in serum. Lumbar puncture and CSF analysis showed: opening pressure: 180mmH2O, protein 39.44mg/dl, glucose 64mg/dl, Cells: 0/ul serum antiganglioside GQ1b assay was not available in Iran. Concerning patient clinical condition a few differential diagnoses was made for her so that Miller Fisher syndrome was on the top of the list; so she electerodiagnostic study (EMG–NCV) was done. There were a few clues in that study supporting peripheral neuropathy.NCV study except bilateral sural absent SNAP were normal and CMAP was completely normal. F wave and H reflex were normal. EMG study was normal. Regarding the patient sever disability and lack of confirming test the patient was treated with 150g IVIG in 5 divided 30g/day dose. In second day of IVIG treatment Patient had significant improvement in ataxia and partial improvement in facial muscle weakness and ophthalmoplegia. In the 3rd day of treatment the ataxia was completely resolved and in later day facial paresis and ophthalmoplegia disappeared so that patient was symptom free in 4th day of IVIG treatment. Patient was discharged to home and followed by her neurologist. At discharge, she was able to walk without assistance.


In patient with ataxia and ophthalmoplegia brain stem involvement is among the most probable diagnoses. Common pathologies that involve brainstem are vascular, Neoplastic and inflammatory. (Box 1). In the presented case involvement of brainstem ruled out by normal brain MRI scan. Wernick’s encephalopathy was another diagnosis that could have such presentation but our patient had no history of alcohol abuse or nutritional deficiency, so this diagnosis was not considered. Acute painful ophthalmoplegia such as bilateral cavernous sinus thrombosis, Tolosa-Hunt syndrome and superior orbital fissure syndrome were not considered because they present with clearly distinctive features and MRI abnormalities. Bickerstaff brainstem encephalitis was considered because of the clinical presentation of multiple cranial nerve palsy and brisk reflexes, but it also seemed unlikely due to absence of disturbance in consciousness or limb weakness, and normal MRI and CSF study.

  • â–¸ Myasthenia gravis
    â–¸ Brainstem stroke (eg, basilar artery occlusion)
    â–¸ Diphtheritic neuropathy
    â–¸ Botulism
    â–¸ Rhombencephalitis

– Infective (eg, listeriosis, tuberculosis, brucellosis, Lyme disease, herpes simplex virus, Epstein–Barr virus, JC virus, toxoplasmosis, cryptococcosis)
– Autoimmune (eg, multiple sclerosis, sarcoidosis, Behçet’s disease, systemic lupus erythematosus
– Malignancy (eg, lymphoma, paraneoplastic syndrome)
â–¸ Basal meningitis (Inflammatory, infective, carcinomatous and lymphomatous)

Box 1: Differential diagnoses for Miller Fisher syndrome, Bickerstaff’s brainstem encephalitis and pharyngeal-cervical-brachial weakness.

Miller Fisher syndrome is a type of GBS that has a classic triad of ataxia ,ophthalmoplegia and areflexia [1]. Limb ataxia may resemble that seen with cerebellar disease. When above mentioned conditions ruled out Miller Fisher syndrome another condition that could present with such symptoms considered; but there was a problem with making the diagnoses of Miller Fisher syndrome which whether this syndrome can present without areflexia. In review of the published literature about Miller Fisher syndrome as in the study by Berlit et al that viewed 223 cases of this syndrome; prevalence of each symptom was investigated so that areflexia was present in 81.6% of cases and in 18.4% DTR was preserved [2]. In another study Yuki et al showed that DTRs could be normal or hyper-excitable during the entire clinical course in approximately 10% of GBS patients [3].A case report by Yuzhu Tang et al was another example [4]. Cranial nerve involvement other than ocular motor nerves(III,IV and VI) as in our patient with facial palsy and 12th nerve involvement can be seen in association with miller fisher syndrome .For example in the study of facial nerve in 45.7%, IX and X in 39.9% , and XII in 13% of patients were involved [2] and in study of Kuwabaraet al facial palsy was present in 35% of miller fisher syndrome cases. Normal CSF study was another feature of our case and in the same study of Kuwabara et al during the first week of illness, CSF albuminocytological dissociation occurred in 37% of cases and CSF pleocytosis was present in only 4 % of the miller fisher syndrome cases. In the second week CSF analysis showed albuminocytological dissociation in 76% of the cases. CSF pleocytosis was present in 5% of the miller fisher syndrome cases [5]. Although CSF protein is mildly elevated, it is less so than in typical GBS.

In Miller Fisher syndrome Electrodiagnostic Studies show loss of sensory potentials, with milder axonal degeneration. Some studies have shown a demyelinating neuropathy, while others suggest purely an axonal process. But regarding past studies sensory nerves abnormality in NCS is more consistent than motor NCS [6,7], and our patient had bilateral absent sural SNAP. Mentioned studies indicate that neither normal DTR nor normal muscle power can rule out the diagnosis of Miller Fisher syndrome; even presence of sever muscle weakness in the setting of ophthalmoplegia and ataxia can make the diagnosis of Miller Fisher syndrome questionable [8].


MFS is characterized by ophthalmoplegia, ataxia and areflexia usually without limb weakness. Patients with additional involvement of the reticular formation, resulting in disturbance of consciousness, are said to have the central nervous system (CNS) subtype, known as Bickerstaff ’s brainstem encephalitis [9]. Indeed some authors consider these two disorders as spectrums of unique condition. MFS can be diagnosed in patients with ophthalmoplegia, ataxia and areflexia. Patients with additional altered mental state have Bickerstaff’s brainstem encephalitis. although in some cases typical clinical picture of MFS may not be present in which ophthalmoplegia or ataxia is absent. Patients with MFS or Bickerstaff’s brainstem encephalitis who develop limb weakness can be diagnosed as having overlap with GBS. A problem that we encountered in confirming the diagnosis was that GQ1b immunoglobulin (Ig)G antibodies assay was not available in Iran [10]. But despite the above limitation we presented this patient as case of Miller Fisher syndrome based on clinical presentation and electerophysiologic findings whereas we lacking the Ab assay to confirm our diagnosis: but regardless of diagnosis dramatic response to IVIG maybe a therapeutic option for physician in similar condition in countries lacking that Ab assay for confirming diagnosis.


  1. Fisher M (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255(2): 57-65.
  2. Berlit P, Rakicky J (1992) The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol 12(1): 57-63.
  3. Yuki N, Kokubun N, Kuwabara S, Sekiguchi Y, Ito M, et al. (2012)Guillain-Barre syndrome associated with normal or exaggerated tendon reflexes. J Neurol 259(6): 1181-1190.
  4. Tang Y, Mamsa KA, Lahiri AK, Carrey Z, Petrillo RL, et al. (2012) A Case of Miller Fisher Syndrome with Unusual Features: Brisk Muscle Stretch Reflexes and Facial Palsy. J Neurol Neurophysiol 3(4): 135.
  5. Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, et al. (2008) Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 255(5): 674-682.
  6. Guiloff RJ (1977)Peripheral nerve conduction in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 40(8): 801-807.
  7. Durand MC, Goulon-Goéau C, Schweitzer A, Chéliout-Héraut F, Raphael JC, et al. (2001) Electrophysiologic study of 10 cases of Miller Fisher syndrome. Rev Neurol (Paris) 157(1): 72-79. [Article in French].
  8. Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 27 Suppl: S21-S24.
  9. Wakerley BR, Yuki N (2015) Mimics and chameleons in Guillain-Barre and Miller Fisher syndromes. Pract Neurol 15(2): 90-99.
  10. Yis, Bayram E, Topçu Y, Karakaya P, Hız Kurul S, et al. (2013) A case of atypical Miller Fisher syndrome with negative anti-GQ1b immunoglobulin G and importance of H reflex. Turk J Pediatr 55(2): 235-236.
© 2014-2016 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy